Publications

Detailed Information

Refracture after Ilizarov osteosynthesis in atrophic-type congenital pseudarthrosis of the tibia

Cited 38 time in Web of Science Cited 38 time in Scopus
Authors

Cho, T-J; Choi, I H; Lee, S M; Chung, C Y; Yoo, W J; Lee, D Y; Lee, J W

Issue Date
2008-04-02
Publisher
British Editorial Society of Bone and Joint Surgery
Citation
J Bone Joint Surg [Br] 2008;90(4):488-493
Keywords
Bone Transplantation/methodsBracesChildChild, PreschoolFemaleHumansInternal FixatorsMalePseudarthrosis/complications/congenital/*radiographyRecurrenceRetrospective StudiesTibia/*injuries/surgeryTibial Fractures/complications/*radiography/surgeryTreatment OutcomeIlizarov Technique/adverse effects
Abstract
We investigated patterns of refracture and their risk factors in patients with congenital pseudarthrosis of the tibia after Ilizarov osteosynthesis. We studied 43 cases in 23 patients. Temporal and spatial patterns of refracture and refracture-free survival were analysed in each case. The refracture-free rate of cumulative survival was 47% at five years and did not change thereafter. Refracture occurred at the previous pseudarthrosis in 16 of 19 cases of refracture. The risk of refracture was significantly higher when osteosynthesis was performed below the age of four years, when the tibial cross-sectional area was narrow, and when associated with persistent fibular pseudarthrosis. Refracture occurs frequently after successful osteosynthesis in these patients. Delaying osteosynthesis, maximising the tibial cross-sectional area and stabilising the fibula may reduce the risk of refracture.
ISSN
0301-620X (Print)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18378925

https://hdl.handle.net/10371/67435
DOI
https://doi.org/10.1302/0301-620X.90B4.20153
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share